Tips from Other Journals
Maintenance Topical Steroid Therapy for Atopic Dermatitis
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2004 Feb 1;69(3):658.
Currently, moderate to severe atopic dermatitis is treated topically with a potent corticosteroid followed by a lower potency formulation, or a short course of corticosteroid followed by emollients. Berth-Jones and colleagues studied a third strategy consisting of initial treatment with fluticasone followed by maintenance emollients with twice weekly fluticasone.
They studied patients 12 to 65 years of age who had recurrent atopic dermatitis and scored higher than 4 on a standardized scale for severity of disease. Patients were excluded from the study if they had other dermatologic conditions that could interfere with assessment of the skin, and if they were receiving medications that could influence the study results. The 376 patients were initially treated with fluticasone propionate cream (0.05 percent) or ointment (0.005 percent) once or twice daily for four weeks. Patients who achieved remission (a score of 1 or lower) were randomly assigned to maintenance treatment with emollient plus fluticasone or placebo on two successive evenings per week for up to 16 weeks. Patients were assessed every two weeks during stabilization and after two, six, 10, and 16 weeks of maintenance. In addition to documentation of dermatitis, patients were assessed for evidence of skin atrophy and adverse effects of treatment.
Of the 295 patients who entered the maintenance phase, 154 used cream, and 141 used ointment. After 16 weeks, 87 patients using fluticasone twice weekly and 46 using placebo in addition to emollients still had controlled dermatitis. The median time to relapse with twice-weekly fluticasone cream or ointment was greater than 16 weeks, significantly longer than median time to relapse with emollient alone (6.1 weeks). The number needed to treat was 2.2 for cream and 6.1 for ointment. The rate of relapse was greater with fluticasone ointment than with cream (40 percent compared with 19 percent), but no differences were noted between twice-daily and once-daily applications.
The authors conclude that once the acute flare of atopic dermatitis has been controlled, fluticasone cream or ointment applied twice weekly added to maintenance emollient therapy significantly extends remission and reduces the risk of relapse.
Berth-Jones J, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ. June 21, 2003;326:1367–70.
Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions